Scientists at Sanford Burnham Prebys have discovered that the SORLA protein protects against tau tangles and synaptic loss in a mouse model of tauopathy, suggesting potential new treatments for Alzheimer’s disease. This finding is significant as it identifies a novel therapeutic target to mitigate neurodegeneration by enhancing SORLA's protective functions. Further research will explore how upregulating SORLA can be applied clinically to treat tau-related dementia disorders.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





